Harrow Health(HROW)
$29.37-0.99 (-3.26%)
HROW
Harrow Health financials statements
$29.37
At close:-0.99 (-3.26%)
Want to see HROW full AI Analyst Report?
Harrow Health (HROW) Ratios
636 Followers
Harrow Health Ratios
HROW's free cash flow for Q3 2026 was $-8.99M. For the 2026 fiscal year, HROW's free cash flow was decreased by $-375.00K and operating cash flow was $-8.62M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.20 | 2.08 | 2.82 | 6.35 | 6.24 |
| Quick Ratio | 2.06 | 1.96 | 2.60 | 6.00 | 5.81 |
| Cash Ratio | 0.76 | 0.52 | 1.50 | 5.17 | 4.34 |
| Solvency Ratio | 0.04 | -0.01 | -0.05 | -0.09 | -0.19 |
| Operating Cash Flow Ratio | 0.46 | -0.24 | 0.08 | 0.09 | 0.52 |
| Short-Term Operating Cash Flow Coverage | 49.45 | 0.00 | 4.76 | 0.00 | 0.00 |
| Net Current Asset Value | $ -135.64M | $ -130.02M | $ -102.68M | $ -11.88M | $ -26.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.63 | 0.59 | 0.61 | 0.71 | 0.79 |
| Debt-to-Equity Ratio | 4.80 | 3.29 | 2.71 | 4.07 | 6.91 |
| Debt-to-Capital Ratio | 0.83 | 0.77 | 0.73 | 0.80 | 0.87 |
| Long-Term Debt-to-Capital Ratio | 0.82 | 0.76 | 0.72 | 0.79 | 0.86 |
| Financial Leverage Ratio | 7.62 | 5.58 | 4.43 | 5.70 | 8.71 |
| Debt Service Coverage Ratio | 1.54 | 0.96 | 0.51 | 0.65 | 0.91 |
| Interest Coverage Ratio | 1.60 | 0.39 | 0.02 | 0.26 | 0.30 |
| Debt to Market Cap | 0.14 | 0.18 | 0.50 | 0.26 | 0.31 |
| Interest Debt Per Share | 7.51 | 7.06 | 6.49 | 4.35 | 3.12 |
| Net Debt to EBITDA | 4.25 | 8.21 | 9.74 | 3.36 | 7.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.05% | 75.33% | 69.55% | 71.35% | 74.87% |
| EBIT Margin | 8.25% | 4.55% | 0.62% | 2.17% | 4.64% |
| EBITDA Margin | 15.47% | 11.08% | 9.18% | 5.36% | 7.04% |
| Operating Profit Margin | 14.18% | 4.42% | 0.33% | 2.17% | 2.23% |
| Pretax Profit Margin | -0.63% | -8.68% | -18.21% | -15.81% | -24.66% |
| Net Profit Margin | -1.89% | -8.76% | -18.75% | -15.90% | -24.85% |
| Continuous Operations Profit Margin | -1.89% | -8.76% | -18.75% | -15.90% | -24.85% |
| Net Income Per EBT | 298.09% | 100.93% | 102.96% | 100.54% | 100.74% |
| EBT Per EBIT | -4.47% | -196.33% | -5501.16% | -730.12% | -1107.43% |
| Return on Assets (ROA) | -1.29% | -4.49% | -7.83% | -8.95% | -18.31% |
| Return on Equity (ROE) | -9.80% | -25.10% | -34.70% | -51.05% | -159.55% |
| Return on Capital Employed (ROCE) | 12.73% | 2.96% | 0.16% | 1.38% | 1.82% |
| Return on Invested Capital (ROIC) | 12.70% | 2.96% | 0.16% | 1.38% | 1.82% |
| Return on Tangible Assets | -2.29% | -8.66% | -16.11% | -10.74% | -22.27% |
| Earnings Yield | -0.29% | -1.46% | -6.68% | -3.48% | -7.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.46 | 1.71 | 3.57 | 13.87 | 16.04 |
| Payables Turnover | 1.92 | 1.27 | 1.85 | 3.94 | 3.52 |
| Inventory Turnover | 5.02 | 4.60 | 3.65 | 3.88 | 4.32 |
| Fixed Asset Turnover | 24.66 | 16.24 | 10.46 | 8.05 | 7.99 |
| Asset Turnover | 0.68 | 0.51 | 0.42 | 0.56 | 0.74 |
| Working Capital Turnover Ratio | 2.55 | 2.12 | 1.38 | 1.18 | 1.79 |
| Cash Conversion Cycle | 31.35 | 5.23 | 5.09 | 27.77 | 3.58 |
| Days of Sales Outstanding | 148.65 | 213.21 | 102.30 | 26.32 | 22.75 |
| Days of Inventory Outstanding | 72.66 | 79.32 | 100.06 | 94.06 | 84.51 |
| Days of Payables Outstanding | 189.96 | 287.30 | 197.27 | 92.61 | 103.68 |
| Operating Cycle | 221.30 | 292.53 | 202.36 | 120.38 | 107.26 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.19 | -0.62 | 0.12 | 0.06 | 0.19 |
| Free Cash Flow Per Share | 1.16 | -1.71 | -4.56 | -0.22 | -0.88 |
| Dividend Paid and CapEx Coverage Ratio | 39.80 | -0.57 | 0.03 | 0.22 | 0.18 |
| Capital Expenditure Coverage Ratio | 39.80 | -0.57 | 0.03 | 0.22 | 0.18 |
| Operating Cash Flow Coverage Ratio | 0.17 | -0.10 | 0.02 | 0.02 | 0.07 |
| Operating Cash Flow to Sales Ratio | 0.16 | -0.11 | 0.03 | 0.02 | 0.07 |
| Free Cash Flow Yield | 2.37% | -5.09% | -40.71% | -1.50% | -10.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -350.00 | -68.47 | -14.96 | -28.77 | -12.84 |
| Price-to-Sales (P/S) Ratio | 6.61 | 5.99 | 2.81 | 4.58 | 3.19 |
| Price-to-Book (P/B) Ratio | 34.35 | 17.17 | 5.19 | 14.69 | 20.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 42.12 | -19.65 | -2.46 | -66.80 | -9.87 |
| Price-to-Operating Cash Flow Ratio | 41.06 | -53.87 | 95.13 | 237.73 | 45.49 |
| Price-to-Earnings Growth (PEG) Ratio | 4.90 | 1.98 | -0.32 | 1.10 | -0.03 |
| Enterprise Value Multiple | 47.00 | 62.26 | 40.32 | 88.69 | 52.31 |
| Enterprise Value | 1.98B | 1.38B | 481.72M | 421.28M | 266.97M |
| EV to EBITDA | 47.00 | 62.26 | 40.32 | 88.69 | 52.31 |
| EV to Sales | 7.27 | 6.90 | 3.70 | 4.76 | 3.68 |
| EV to Free Cash Flow | 46.31 | -22.63 | -3.24 | -69.43 | -11.39 |
| EV to Operating Cash Flow | 45.15 | -62.05 | 125.45 | 247.09 | 52.53 |
| Tangible Book Value Per Share | -3.36 | -3.30 | -2.77 | 0.04 | -0.24 |
| Shareholders’ Equity Per Share | 1.43 | 1.95 | 2.16 | 1.00 | 0.42 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.98 | -0.01 | -0.03 | -0.01 | -0.01 |
| Revenue Per Share | 7.41 | 5.60 | 3.99 | 3.23 | 2.71 |
| Net Income Per Share | -0.14 | -0.49 | -0.75 | -0.51 | -0.67 |
| Tax Burden | 2.98 | 1.01 | 1.03 | 1.01 | 1.01 |
| Interest Burden | -0.08 | -1.91 | -29.24 | -7.30 | -5.31 |
| Research & Development to Revenue | 0.05 | 0.06 | 0.05 | 0.03 | 0.15 |
| SG&A to Revenue | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.05 | 0.09 | 0.12 | 0.09 | 0.08 |
| Income Quality | -8.54 | 1.27 | -0.16 | -0.12 | -0.28 |
Currency in USD
